Ibuprofen Lysine

5 trials 2 recruiting MMusculoskeletal

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

3 Completed trials

3 Sponsors

6 Countries

Phase IV

Phase I (FiH)

Phase IV: 2 Phase I (FiH): 3

Oversight events:

6 temporary halts 1 urgent safety measure 1 unexpected event across 2 trials

View oversight register →

Indications tested

Axial spondyloarthritis 1 Glycogen storage disease type I 1

Sponsors using this IMP

Moderna Inc. 3 Dicofarm S.p.A. 1 St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr 1

All trials

5 total

A study to investigate the safety and efficacy of mRNA-3927 in participants with genetically confirmed propionic acidemia Recruiting

2022-502910-10-00 Phase I (FiH) 4 countries Moderna Inc.
Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis Recruiting

2024-513213-13-00 Phase IV 1 country St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr
A Phase 1/2, adaptive, open-label, single ascending dose to multiple ascending dose study to evaluate the safety, tolerability, pharmacokine… Ended

2022-502963-39-00 Phase I (FiH) 4 countries Moderna Therapeutics Inc.
A dose-finding study to evaluate mRNA-3210 in participants with phenylketonuria Ended

2023-506963-32-00 Phase I (FiH) 3 countries Moderna Therapeutics Inc.
Randomized, single blind, non-inferiority study on the speed of action of lysin ibuprofen suspension vs ibuprofen suspension in the treatmen… Ended

2023-507510-27-00 Phase IV 1 country Dicofarm S.p.A.

Showing 1–5 of 5 trials

← All drugs A–Z